Pharmacokinetics and Pharmacodynamics of Cannabinoids
Top Cited Papers
- 1 January 2003
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 42 (4) , 327-360
- https://doi.org/10.2165/00003088-200342040-00003
Abstract
Δ9-Tetrahydrocannabinol (THC) is the main source of the pharmacological effects caused by the consumption of cannabis, both the marijuana-like action and the medicinal benefits of the plant. However,...Keywords
This publication has 258 references indexed in Scilit:
- Plasma concentrations of delta-9-tetrahydrocannabinol in dams and fetuses following acute or multiple prenatal dosing in ratsPublished by Elsevier ,2002
- Complex pharmacology of natural cannabivoids: Evidence for partial agonist activity of Δ9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptorsLife Sciences, 1998
- An efficient new cannabinoid antiemetic in pediatric oncologyLife Sciences, 1995
- Metabolism of Δ9-tetrahydrocannabinol by cytochrome P450 isozymes purified from hepatic microsomes of monkeysLife Sciences, 1995
- Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDSJournal of Pain and Symptom Management, 1995
- Cytoskeletal organization following cannabinoid treatment in undifferentiated and differentiated PC12 cellsBiochemistry and Cell Biology, 1992
- Antagonism of marihuana effects by indomethacin in humansLife Sciences, 1991
- Nicotine and cannabinoids as adjuncts to neuroleptics in the treatment of tourette syndrome and other motor disordersLife Sciences, 1989
- Kinetic study of smoking marijuanaJournal of Pharmacokinetics and Biopharmaceutics, 1982
- Evidence that cannabidiol does not significantly alter the pharmacokinetics of tetrahydrocannabinol in manJournal of Pharmacokinetics and Biopharmaceutics, 1981